#$%^&*AU2016200598A120160225.pdf#####NOVEL ANTITUMORAL USE OF CABAZITAXEL AVENTIS PHARMA S.A. Abstract The invention relates to a compound of formula: CH3 CH3 0 O CH3 H3 C O H C CH H3C HN , HCH30 HO H CH CH HOO which may be in base form or in the form of a hydrate or a solvate, in combination with prednisone or prednisolone, for its use as a medicament in the treatment of prostate cancer, particularly metastatic prostate cancer, especially for patients who are not catered for by a taxane-based treatment.